Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| Reactant | HCID 59435985 | HCID 59435985 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 59436088 | HCID 59436088 | — |
Reaction Steps
To a solution of 9-bromo-5((2,6-dichloro-4-fluorophenyl){[2-(trimethylsilyl)ethoxy]methyl}amino)-2-{[2-(trimethylsilyl)ethoxy]methyl}benzo[c]-2,6-naphthyridin-1(2H)-one (58 mg, 0.08 mmol) in dioxane (2 ml) was added morpholine (14.16 mg, 0.16 mmol), xantphos (9.41 mg, 0.02 mmol), cesium carbonate(79 mg, 0.24 mmol) and Pd2(dba)3 (7.44 mg, 8.13 μmol). The solution was degassed by bubbling nitrogen for few minutes and heated to 100° C. in a sealed tube for 16 h. After cooling to room temperature, the reaction mixture was filtered and the filtrate was evaporated under vacuum to afford the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08349865B2 |
|---|
| Source dataset | uspto-grants-2013_01 |
|---|
| ORD ID | ord-b386bf126f2843128195622f856e7aff |
|---|
| Source note | uspto-grants-2013_01 |
|---|